Merial entered the cattle implant market with the introduction of Duralease? (estradiol benzoate), the first of its kind implant that uses liquid suspension technology.
Merial entered the cattle implant market with the introduction of Duraleaseâ¢ (estradiol benzoate), the first of its kind implant that uses liquid suspension technology. The product is the only implant to combine the benefits of a sustained-release estradiol benzoate implant with the consistency of a patented Theraphaseâ¢ (microencapsulation) technology.
This technology involves embedding a drug in a matrix of biodegradable strands of polymer. These strands form a microscopic sphere that can be easily injected to provide a long-lasting drug release.
This suspension implant uses a standard syringe to deliver a small 1-mL dose, which makes it less invasive and eliminates special equipment and pellets. With the same formula for steers and heifers, the product provides convenience and flexibility in an easy-to-administer liquid implant, the company adds.
For fastest response, call